- Trials with a EudraCT protocol (665)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
665 result(s) found for: Ultrasound therapy.
Displaying page 1 of 34.
EudraCT Number: 2014-003469-10 | Sponsor Protocol Number: MUST14 | Start Date*: 2015-08-05 |
Sponsor Name:VU University Medical Center | ||
Full Title: The application of contrast-enhanced ultrasound to facilitate thrombolysis in patients with acute peripheral arterial occlusions. | ||
Medical condition: Acute peripheral arterial occlusions. Acute peripheral arterial occlusive disease can be caused by a blood clot blocking an artery in an arm or leg. This is an emergency situation that can result i... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001053-44 | Sponsor Protocol Number: Carotis-Rivaroxaban_CEUS_001 | Start Date*: 2020-09-30 | |||||||||||
Sponsor Name:Rigshospitalet, Department of Vascular Surgery | |||||||||||||
Full Title: Stabilization of vulnerable atherosclerotic carotid plaques by Rivaroxaban as evaluated by 3D contrast enhanced ultrasound (CEUS) | |||||||||||||
Medical condition: Patients with - Stable peripheral artery disease and - Asymptomatic, atherosclerotic plaque/stenosis in the carotid artery; asymptomatic regarding cerebral ischaemia including stroke and transient... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004117-40 | Sponsor Protocol Number: Q03.13.01 | Start Date*: 2013-12-19 |
Sponsor Name:Fidia Farmaceutici SpA | ||
Full Title: Randomized, controlled, double-blinded clinical trial, with open-label extension on the efficacy of ultrasound guided injection of hyaluronic acid (500-730 KDa) (HYALGAN®) versus saline solution in... | ||
Medical condition: Achilles tendinopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004112-63 | Sponsor Protocol Number: DutchSTRIDER | Start Date*: 2014-08-13 |
Sponsor Name:Academic Medical Center | ||
Full Title: The Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset intrauterine growth Restriction) Trial | ||
Medical condition: Fetal growth restriction | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005444-35 | Sponsor Protocol Number: C4591015 | Start Date*: 2021-04-15 | |||||||||||
Sponsor Name:BioNTech SE | |||||||||||||
Full Title: A PHASE 2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SARS-COV-2 RNA VACCINE CANDIDATE (BNT162b2) AGAINST COVID-19 IN HEAL... | |||||||||||||
Medical condition: Protection against COVID-19 | |||||||||||||
|
|||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003099-39 | Sponsor Protocol Number: LWH0604 | Start Date*: 2008-08-21 |
Sponsor Name:Liverpool Women's NHS Foundation Trust Hospital | ||
Full Title: A Randomised Controlled Trial of Thyroxine in Preterm Infants Under 28 weeks' Gestation. | ||
Medical condition: Hypothyroidism is a condition where there is a lack of thyroid hormone in the body. Thyroid hormones are important for normal brain development and growth. Children who are born with low thyroid ho... | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002650-67 | Sponsor Protocol Number: IBERepic/2018 | Start Date*: 2018-11-15 |
Sponsor Name:Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274) | ||
Full Title: Comparison of the efficacy of autologous platelet rich plasma injections, and extracorporeal shock wave therapy, in the treatment of work –related lateral epicondylitis. | ||
Medical condition: The epicondylitis is an overuse injury, in most cases, is a self-limited course and responds well to conservative treatment. Its etiology is degenerative and is related to a repetitive overuse and ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002266-40 | Sponsor Protocol Number: CAIN457ADE02 | Start Date*: 2013-12-09 |
Sponsor Name:Novartis Pharma GmbH | ||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, exploratory evaluation of surrogate markers of cardiovascular risk in patients with active chronic plaque-type psoriasis treated for 52 ... | ||
Medical condition: active chronic plaque-type psoriasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002311-39 | Sponsor Protocol Number: 101069207 | Start Date*: 2022-09-07 |
Sponsor Name:University Of Cyprus | ||
Full Title: Phase II trial for the use of ketotifen to enhance therapy in patients with sarcoma receiving standard chemotherapy | ||
Medical condition: Patients with sarcoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CY (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000467-23 | Sponsor Protocol Number: 1 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||
Full Title: Maternal and fetal haemodynamic response to Nifedipine tocolysis in normotensive pregnant women. | ||||||||||||||||||||||||||||
Medical condition: A more detailed investigation of the haemodynamic effect on the mother and fetus of Nifedipine tocolysis . Tocolysis will be used to facilitate external cephalic version for breech presentation at ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005346-10 | Sponsor Protocol Number: AUH-TFB-SR | Start Date*: 2014-11-21 | ||||||||||||||||
Sponsor Name:Thomas Fichtner Bendtsen | ||||||||||||||||||
Full Title: Shamrock versus Lumbar Ultrasound Trident – Ultrasound guided block of the lumbar plexus | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004491-17 | Sponsor Protocol Number: REMODEL | Start Date*: 2021-03-31 |
Sponsor Name:UZ Brussel | ||
Full Title: Dydrogesterone versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in hormone replacement therapy (HRT) frozen embryo transfer (FET) cycles. | ||
Medical condition: progesterone as luteal phase supplementation in frozen embryo transfer cycles | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004122-28 | Sponsor Protocol Number: RR13/10782 | Start Date*: 2015-03-02 |
Sponsor Name:The Leeds Teaching Hospitals NHS Trust | ||
Full Title: An investigator‐initiated double‐blind, parallel‐group randomised controlled trial of GOLimumab and Methotrexate versus Methotrexate in very early PsA using clinical and whole body MRI outcomes: th... | ||
Medical condition: Adult patients with a diagnosis of Psoriatic Arthritis(PsA), (Caspar criteria) of less than 24-month duration. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000879-24 | Sponsor Protocol Number: IJB-BC-NEORHEA-2016 | Start Date*: 2017-03-23 | |||||||||||
Sponsor Name:Institut Jules Bordet | |||||||||||||
Full Title: Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined with Endocrine Therapy in Estrogen Receptor Positive/ HER2 Negative Breast CAncer | |||||||||||||
Medical condition: Primary breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002304-16 | Sponsor Protocol Number: 130873-2004 | Start Date*: 2005-06-14 |
Sponsor Name:South Tees Hospitals NHS Foundation Trust | ||
Full Title: The STARS (STeroids Against Re-Stenosis) Trial [THE USE OF Peri-PROCEDURAL ORAL CORTICOSTERIODS TO PREVENT IN-SEGMENT RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION.] | ||
Medical condition: coronary artery disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004953-17 | Sponsor Protocol Number: TUD-OCTpro-053 | Start Date*: 2012-05-25 | ||||||||||||||||
Sponsor Name:Technical university Dresden | ||||||||||||||||||
Full Title: Measurement of epidermal and dermal thickness under therapy with Pimecrolimus 1 % Creme (Elidel® 1 % Creme), Hydrocortisonacetat 1 % Creme (Hydrogalen® Creme), Betamethasonvalerat 0,1 % Creme (Bet... | ||||||||||||||||||
Medical condition: - age 18-40 years - health volunteers - normal dermis - written accordance of the test person | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-005145-51 | Sponsor Protocol Number: 13-152 | Start Date*: 2015-09-18 |
Sponsor Name:Maastricht University Medical Centre | ||
Full Title: A randomised controlled multicenter trial comparing ultrasound-accelerated catheter-directed thrombolysis, combined with standard anticoagulant therapy, with standard anticoagulant therapy alone, f... | ||
Medical condition: Acute primary iliofemoral deep vein thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003735-28 | Sponsor Protocol Number: SONAZOID-PANCREAS-001 | Start Date*: 2021-03-05 | ||||||||||||||||
Sponsor Name:Helse Bergen HF, Department of Medicine | ||||||||||||||||||
Full Title: The role of sonoporation-enhanced treatment with Gemcitabine, Nab-Paclitaxel and FOLFIRINOX in patients with inoperable pancreatic cancer. | ||||||||||||||||||
Medical condition: Histologically verified, locally advanced (nonresectable Stage II/III) or metastatic (Stage IV) adenocarcinoma of the pancreas. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NO (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001399-40 | Sponsor Protocol Number: RECHMPL20_0092 | Start Date*: 2021-06-02 |
Sponsor Name:University hospital of Montpellier | ||
Full Title: Amlodipine interest in HRT (Hormone Replacement Therapy) cycle for frozen embryo transfer in the uterine pulsatility indices correction: double-blind randomized controlled trial | ||
Medical condition: uterine arteries pulsalility index for patients awaiting frozen embryo transfer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023831-40 | Sponsor Protocol Number: I124 | Start Date*: 2011-04-12 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO | |||||||||||||
Full Title: Study for metastatic thyroid cancer using 124i and [18F] FDG PET / CT in patients with elevated values of Tg and / or AbTg with negative ultrasonography of the neck, previously treated with thyroid... | |||||||||||||
Medical condition: Only patiens | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
